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Background: Alternanthera sessilis is a popular vegetable and used in traditional medicinal practice of Bangladesh
and other parts of Asia to relive tiredness, laziness, and sleeps as well as pain and inflammation. However, no report
was found on the neuropharmacological and analgesic activity of this plant to-date. Present study was undertaken
to evaluate the neuropharmacological and analgesic activity of the ethanol extract of A. sessilis whole plant (ETAS)
in mice models.
Methods: Central stimulating activity was investigated by pentobarbitone induced sleeping time, open field, and
hole cross tests. Analgesic activity was evaluated by acetic acid induced writhing and hot-plate methods. The tests
were performed at 250 and 500 mg/kg body weight dose levels.
Results: In sleeping time test, ETAS significantly (p < 0.001) increased the onset of sleep, and decreased the duration of
sleep. In open field and hole cross tests, ETAS significantly (p < 0.001) increased the movements of mice which persisted
throughout the study period. In writhing test, ETAS showed, significant (p < 0.001) inhibition of writhing reflex. In hot
plate test, ETAS significantly (p < 0.001) raised the pain threshold. In HPLC analysis for polyphenols, (+)-catechin,
rutin, ellagic acid, and quercetin were detected in ETAS (117.72, 490.74, 3007.26, and 13.85 mg/100 g of dry
extract, respectively).
Conclusion: Present study supported the traditional uses of A. sessilis and indicated that the plant can be a
potential source of bioactive molecules.
Keywords: Alternanthera sessilis, Central stimulating activity, Pentobarbitone induced sleeping time, Acetic acid
induced writhing testBackground
Alternanthera sessilis (L.) R.Br. ex DC. (Family: Amarantha-
ceae) is an aquatic plant commonly growing in Bangladesh.
In Bangladesh, it is known as Chanchi, Haicha, Sachi-shak,
and distributed all over the country especially in moist
areas. It also grows in many other Asian countries including
India, Nepal, Sri Lanka, Malaysia, Indonesia, China, and
Taiwan [1].
A. sessilis is widely used as vegetable in Asia, and occa-
sionally cultivated for its use in herbal medicine. Tradition-
ally, the leaves of A. sessilis is used in skin diseases, eye
diseases, wound healing and as an antidote for snake bite* Correspondence: uddinsj@yahoo.com
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unless otherwise stated.[2]. In local communities of Bangladesh and other South
Asian countries, the plant is used in the treatment of
rheumatism and painful swellings associated with wounds.
A decoction of A. sessilis is also used to alleviate pain and
intestinal inflammation [3]. The plant A. sessilis is well
known for its stimulant activity and used for removing
tiredness, laziness, and sleeps [1]. In some parts of India,
including Bihar, poultice of pounded fresh material is used
for sprains, burns, and eczema [4]. The plant is also used
in the treatment of malaria, diarrhoea, dysentery, post-
natal complaints, night blindness, and helminthiasis [1].
Anthelmintic activity is known to be produced when the
juice of A. sessilis is administered with two spoons of warm
water in an empty stomach [1].
The plant is reported to have diuretic [5], haematinic
[6], antioxidant [7], anti-inflammatory [4], cytotoxic [8],l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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microbial, and wound healing [12] properties. The herb is
also reported as febrifuge, galactagogue, abortificient, and
used in the treatment of indigestion [13]. The plant is re-
ported to contain lupeol, α and β-spinasterol, β-sitosterol,
stigmasterol, and campesterol [14,15].
Although the plant has traditional uses as pain killer
or stimulant (removes tiredness, laziness, and sleeps),
but there is no scientific report to-date on its neuro-
pharmacological and analgesic activity. As a part of our
continuing screening of medicinal plants with analgesic
and neuropharmacological activity [16-18], here we now
report the central-stimulating and analgesic activity of
the ethanol extract of A. sessilis in mice models.
Methods
Plant material
Whole plants of A. sessilis were collected from Gopalgonj,
Bangladesh in October 2011, and were identified by the
experts at Bangladesh National Herbarium, Dhaka. A vou-
cher specimen (DACB 36542) was deposited there for fu-
ture reference. Plants were washed to remove extraneous
materials and then shed dried for several days. Shed-dried
plant material was ground into a coarse powder with the
help of a mechanical grinder, and the plant material was
kept in air tight container until the extraction process
commenced.
Extraction
Powdered plant material (380 g) was extracted with 90%
ethanol in distilled water for three days with occasional
shaking. The extract was filtered and dried in a rotary
vacuum evaporator at 45°C under reduced pressure to
obtain the crude extract (ETAS) (yield: 5.3% extract of
dried plant material).
Test animals
Young Swiss Albino mice of either sex, aged 4–5 weeks
and average weight of 20–25 g were purchased from the
Animal Resources Branch of International Centre for
Diarrhoeal Disease Research, Bangladesh (ICCDR,B)
and used for the pharmacological investigations. The
animals were kept in polypropylene cages under stand-
ard laboratory condition maintained at room temperature
of 25 ± 2°C, relative humidity of 56-60%, and proper
dark–light cycle. The animals were supplied with ICDDR,
B formulated rodent food and water ad libitum. The
experimental protocols were approved by the ethical
committee of Pharmacy Discipline, Life Science School,
Khulna University, Bangladesh.
Chemicals and drugs
Gallic acid, (+)-catechin hydrate, vanillic acid, caffeic acid,
(−)-epicatechin, p-coumaric acid, rutin hydrate, ellagicacid, and quercetin were obtained from Sigma-Aldrich
(St. Louis, MO, USA). Acetonitrile (HPLC), methanol
(HPLC), acetic acid (HPLC), and ethanol were pur-
chased from Merck (Darmstadt, Germany). Tween-80 was
obtained from Loba Chemie Pvt Ltd, India. Diclofenac so-
dium, caffeine (Beximco Pharmaceuticals Ltd, Bangladesh),
morphine (Popular Pharmaceuticals Ltd, Bangladesh), and
pentobarbitone (Incepta Pharmaceuticals Ltd, Bangladesh)
were used as reference drugs in the present study.
Grouping and dosing
Animals were randomly divided into four groups, each
comprising six animals. Control group was treated with
Tween 80 (1% w/v in water) at a volume of 10 ml/kg; ex-
tract groups were treated with ETAS at doses of 250 and
500 mg/kg; positive controls were treated with caffeine
(20 mg/kg) for pentobarbitone-induced sleeping time,
morphine (5 mg/kg) for hot plates test, or diclofenac so-
dium (25 mg/kg) for writhing test. Administration of A.
sessil extract was assumed to be safe based on its trad-
itional use [1,2,11] as well as previous studies made using
the plant [4,10,12]. These reports were also used as a basis
for dose selection. Both test and control treatments were
administered orally except for hot-plate test. In hot-plate
test, intraperitoneal (i.p.) route was selected for adminis-
tration of the treatments.
Pentobarbitone-induced sleeping time test
Test groups and control received respective treatments
at proper doses as mentioned earlier, while the positive
control group received caffeine at the dose of 20 mg/kg,
i.p.. Thirty minutes later, pentobarbitone (50 mg/kg, i.p.)
was administered to each mouse to induce sleep. Onset
of sleep and duration of sleep were recorded for each
group and compared with the control [18].
Open field test
Experimental mice of test groups and control were ad-
ministered with the respective treatments at the proper
doses as mentioned earlier. The mice were placed on the
floor of an open field chamber (100 cm × 100 cm ×
40 cm) divided into series of squares colored black and
white in an alternative format. The number of squares
visited by each group was recorded for 3 min at 0, 30,
60, 90, 120, 180, and 240 min during the observation
period and compared with the control [18].
Hole cross test
For the hole cross test, a plastic made transparent cage
(30 cm × 20 cm × 14 cm) was provided with a partition
fixed in the middle of the cage. A hole of 3 cm in diam-
eter was made in the partition at the height of 7.5 cm
above the floor of the plastic cage. Experimental mice
were provided with the respective treatments at the
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either side of the partition, and the number of hole
crossed by each group was recorded for 3 min at 0, 30,
60, 90, 120, 180 and 240 min during the observation
period. Results of the test groups were compared with
the control [17].Acetic acid induced writhing test
Analgesic activity of ETAS was evaluated by acetic acid
induced writhing method [19]. Test groups and control
received respective treatments at the proper doses, while
the positive control group received diclofenac sodium
(25 mg/kg, p.o.). Thirty minutes later, acetic acid (0.7%,
10 ml/kg, i.p.) was administered to each mouse to in-
duce abdominal contraction known as writhing [20].
After an interval of 5 min, number of writhes for each
group was counted for 10 min and recorded. The num-
ber of writhes of test groups at different dose levels, and
standard were compared with the control.Hot-plate test
Mice of both sexes were screened based on their re-
sponse when subjected to hot-plate. Test groups and
control received their respective treatments at the
proper doses as mentioned earlier, while the positive
control group received morphine (5 mg/kg, i.p.). Pain
stimulus was produced by placing the animals on hot-
plate maintained at the temperature of 55 ± 0.5°C [21].
Paw licking or jumping off the plate was considered as
response to pain stimulus. Reaction time for each group
was recorded at 0, 30, 60, 90 and 120 min during the ob-
servation period [22]. To avoid any possible accidental
paw damage, a cut-off point of 15 sec was considered.
Reaction time of the extract and standard was compared
with the control [23].Phytochemical group test
Phytochemical group test of ETAS was performed using
standard test methods for the identification of reducing
sugars, alkaloids, steroids, tannins, glycosides, gums/car-
bohydrates, flavonoids, and saponins [24].Table 1 Effect of ETAS on pentobarbitone-induced sleeping t




Control - 11.24 ± 1.80
Caffeine 20 58.63 ± 1.84*
A. sessilis 250 32.45 ± 2.89*,#
500 53.67 ± 2.60*
Values are mean ± SEM. *p < 0.001 vs. control, #p < 0.01 vs. caffeine, the data was anHPLC analysis for polyphenolic constituents
HPLC analysis was conducted on a Dionex UltiMate
3000 Rapid Separation LC (RSLC) system (Thermo Fisher
Scientific Inc., MA, USA) following the method as de-
scribed by Chuanphongpanich and Phanichphant with
some modifications [25]. A quaternary rapid separation
pump (LPG-3400RS) and rapid separation photodiode
array detector (DAD-3000RS) were coupled with the
system. Compounds were separated on an Acclaim® C18
(4.6 × 250 mm; 5 μm) column (Dionex, USA) at 30°C
using a temperature-controlled column compartment
(TCC-3000). Data acquisition, peak integration, and
calibrations were accomplished using Dionex Chrome-
leon software (Version 6.80 RS 10). A gradient elution
was programmed with 5%A/95%B from 0 to 9 min, 10%
A/80%B/10%C from 10 to 19 min, 20%A/60%B/20%C
from 20 to 30 min, flushing and post run equilibration
of the column with 100%A for 5 min where A, B and C
stand for acetonitrile, acetic acid solution of pH 3.0 and
methanol, respectively. The flow rate was kept constant
throughout the analysis at 1 ml/min and the injection
volume was 20 μl. For detection of the compounds; the
UV detector was adjusted at 280, 320, and 380 nm con-
secutively for 18, 24 and 30 min while the photodiode
array detector was adjusted to acquisition range from
200 to 700 nm throughout the entire run time. For cali-
bration curve preparation, a stock solution was pre-
pared in methanol containing ellagic acid, gallic acid,
vanillic acid, (+)-catechin, (−)-epicatechin, p-coumaric
acid, rutin (20 μg/ml each), caffeic acid (8 μg/ml) and
quercetin (6 μg/ml). A solution of ETAS was prepared in
methanol having the concentration of 5 mg/ml. All solu-
tions (mixed standards, ETAS, and spiked solution) were
filtered through 0.2 μm nylon syringe filter (Sartorius,
Germany) and degassed in an ultrasonic bath (Hwashin,
Korea) for 15 min before HPLC analysis.
Statistical analysis
Results were expressed as mean ± SEM (Standard error
for mean). All statistical analysis was carried out using
one-way or two-way analysis of ANOVA followed by
Bonferroni’s test. Analysis was performed in Prism 5.0
(GraphPad software Inc., San Diego, CA). Results were







- 101.57 ± 2.67 -
421.62 62.56 ± 2.23* 38.41
188.70 88.67 ± 2.90# 12.70
377.49 78.13 ± 2.31*,# 23.08
alyzed by one way ANOVA followed by Bonferroni’s test.
Figure 1 Effect of ETAS in open field test in mice. *p < 0.001 vs. control, the data was analyzed by two way ANOVA followed by Bonferroni’s test,
values are mean ± SEM (n =6).
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Pentobarbitone-induced sleeping time test
ETAS significantly (p < 0.001) increased the onset of
pentobarbitone-induced sleep and decreased total
sleeping time in mice at both dose levels. ETAS
showed 188.70 and 377.49% increase in the onset of
sleep and 12.70 and 23.08% decrease of the duration of
sleep at the doses of 250 and 500 mg/kg, respectively
(Table 1). Caffeine, used as standard in this study,
showed 421.62% increase in the onset of sleep and
38.41% decrease of the duration of sleep at the dose of
20 mg/kg.Figure 2 Effect of ETAS in hole cross test in mice. *p < 0.001 vs. control
values are mean ± SEM (n =6).Open field test
In open field test, ETAS showed significant (p < 0.001)
increase in locomotion in mice from the second obser-
vation period (30 min) and continued throughout the
entire observation period of 240 min. Maximum effect
was noted at 60 min and a successive decrease in stimu-
lating activity was observed with the passage of time for
both dose groups (Figure 1).
Hole cross test
In hole cross test, ETAS significantly (p < 0.001) in-
creased locomotor activity in mice at both dose levels, the data was analyzed by two way ANOVA followed by Bonferroni’s test,
Table 2 Effect of ETAS on acetic acid induced writhing in
mice
Treatment (n =6) Dose (mg/kg) No. of writhes % inhibition
Control - 21.00 ± 0.57 -
Diclofenac sodium 25 5.00 ± 0.36* 76.19
A. sessilis 250 13.17 ± 0.47*,# 37.28
500 8.50 ± 0.42*,# 59.52
Values are mean ± SEM. *p < 0.001 vs. control, #p < 0.001 vs. diclofenac sodium,
the data was analyzed by one way ANOVA followed by Bonferroni’s test.




Reducing sugar Fehling’s test +
Benedict’s test +
Alkaloid Dragendorff’s test +
Steroid and terpenoid Salkowski’s test +
Libermann-Burchard reagent +
Tannin Ferric chloride test +






Gum/Carbohydrate Molish’s test -
Flavonoid Shinoda test +
Alkaline reagent test +
Saponin Frothing test -
* “+” indicates presence and “-” indicates absence.
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motor activity was revealed at 60 min for both the doses
tested, and activity persisted throughout the observation
period following a trend of gradual decrease in activity
with the passage of time (Figure 2).
Acetic acid induced writhing test
ETAS showed 37.28 and 59.52% inhibition of writhing at
the doses of 250 and 500 mg/kg body weight, respectively,
whereas diclofenac sodium showed 76.19% inhibition at
the dose of 25 mg/kg as compared to the control, and the
results were statistically significant (p < 0.001) (Table 2).
Hot-plate test
The ETAS showed maximum reaction time of 6.87 and
7.28 sec at 60 min at the doses of 250 and 500 mg/kg,
respectively while morphine showed the maximum reac-
tion time of 10.05 sec at 90 min at the dose of 5 mg/kg
(Table 3). The results indicated that the extract signifi-
cantly (p < 0.001) raised pain threshold as compared to
control and the activity was persistent throughout the
entire observation period of 120 min.
Phytochemical group test
The phytochemical group test indicated the presence of
reducing sugars, alkaloids, steroids, terpenoids, tannins
and flavonoids (Table 4).
HPLC analysis
HPLC analysis of ETAS showed very high levels of ellagic




(mg/kg) 0 min 30 min
Control - 4.23 ± 0.07 4.21 ± 0.05
Morphine 5 4.02 ± 0.05 6.03 ± 0.05*
A. sessilis 250 4.49 ± 0.06 5.20 ± 0.05*,
500 4.48 ± 0.07 5.78 ± 0.03*
Values are mean ± SEM. *p < 0.001 vs. control, #p < 0.001 vs. morphine, the data warepectively). (+)-Catechin and quercetin were also identified
but with comparatively lower concentrations (117.72
and 13.85 mg/100 g of extract, respectively) (Table 5). The
chromatogram also displayed peaks in regions that repre-
sent simple polyphenols, catechins, anthocyanins, flavonoid
aglycones and flavonoid glycosides (Figure 3) [26]. Chro-
matogram of mixed standards is mentioned in Figure 4.Discussion
Pentobarbitone-induced sleeping time, open field, and
hole cross tests are most widely used methods for cen-
tral behavioral analysis and are sensitive ways to evaluate
central stimulating activities of drugs and crude plant
extracts [27,28]. Pentobarbitone, a short-acting barbitur-
ate, when given in appropriate dose, induces sedation in
animals by stimulating the inhibitory neurotransmitter
gamma-aminobutyric acid (GABA) mediated postsynap-
tic inhibition through allosteric modification of GABAA
receptors [29]. In the present study, ETAS significantly
increased the time required for the onset of sleep and
decreased the duration of sleep as compared to control,Reaction time (sec)
60 min 90 min 120 min
4.18 ± 0.04 4.23 ± 0.05 4.17 ± 0.05
8.03 ± 0.07* 10.05 ± 0.09* 8.91 ± 0.09*
# 6.87 ± 0.03*,# 5.92 ± 0.07*,# 5.06 ± 0.05*,#
7.28 ± 0.08*,# 6.14 ± 0.05*,# 5.51 ± 0.05*,#
s analyzed by two way ANOVA followed by Bonferroni’s test.
Table 5 Polyphenolic compounds in ETAS identified by
HPLC analysis





RSD: Relative standard deviation.
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activity. ETAS also increased the locomotor activity in
open field and hole cross tests, which further strength-
ened central stimulating activity of the extract [30]. The
probable mechanism of central stimulant effect of the
ETAS may be due to the antagonism of inhibitory
neurotransmitter, alteration of presynaptic control of in-
hibitory neurotransmitter release or enhancement of the
excitatory neurotransmitter. Quercetin, identified in ETAS,
has been reported to have central stimulant effect via
antagonism of adenosine A1 receptors [31]. Based on a
comparative molecular field analysis model, some flavonoid
derivatives were found to be potential adenosine receptorFigure 3 HPLC chromatogram of ETAS. Peaks 1: (+)-catechin, 2: rutin, 3:antagonists [32]. The ETAS extract showed positive results
for alkaloids and it is well-known that many alkaloids includ-
ing caffeine, cocaine, cathinone, nicotine, and yohimbine,
posess central stimulant effect [33]. Therefore, the identi-
fied polyphenols and alkaloids might contribute in the ob-
served central stimulant effect of A. sessilis extract.
Several analgesic drugs, including NSAIDs, opiates,
and steroids are available for the management of pain,
but these drugs are often associated with severe side ef-
fects. NSAIDs cause gastric ulceration, opiates can de-
velop dependence, and steroids are associated with side
effects affecting hormonal regulation [34]. Many periph-
erally or centrally acting analgesics have been isolated
from plants and thus require extensive studies to explore
more analgesic agents from natural sources [35]. Results
of the present study revealed that ETAS has peripheral
and centrally acting analgesic activity. The plant is re-
ported to contain lupeol [14,15] and in a recent study,
lupeol showed analgesic activity in an inflammatory
model of pain through the inhibition of IL-4, IL-5 and
IL-13 [36]. The plant is also rich in sterols [14,15] and
therefore, the role of other sterols in the observed anal-
gesic activity cannot be ruled out [37]. In acetic acid in-
duced writhing model, acetic acid increases the level ofellagic acid, 4: quercetin.
Figure 4 HPLC chromatogram of a standard mixture of polyphenolic compounds. Peaks: 1: gallic acid; 2: (+)-catechin; 3: vanillic acid;
4: caffeic acid; 5: (−)-epicatechin; 6: p-coumaric acid; 7: rutin; 8, ellagic acid; 9: quercetin.
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lipoxygenase derived icosanoids in the peritoneal fluid
[39]. Abdominal contraction or writhing in mice occurs
because of the release of these pain mediators. The ex-
tract significantly reduced the number of writhes, and
the probable mechanism might involve the inhibition of
the release of pain mediators by acting on visceral recep-
tors sensitive to acetic acid.
Hot-plate test is a widely used model for neurologic
pain, and centrally acting analgesic agents can increase
reaction time in hot-plate test through their action at
the spinal cord level [40,41]. Morphine used as the
standard in this study, acts through binding with opioid
receptors (μ, δ and κ) present in presynaptic and post-
synaptic membrane. The result of hot plate test indicates
that the extract also possesses the ability to reduce cen-
trally mediated pain.
In the phytochemical group tests of ETAS, some major
phytochemicals, namely, reducing sugars, alkaloids, ste-
roids, terpenoids, tannins, and flavonoids were identified. It
is well established that various terpenoids, favonoids, ste-
roids are involved in analgesic activity [42]. In addition,
polyphenolic constituents, (+)-catechin, ellagic acid, and
rutin identified in the HPLC analysis, which showed anal-
gesic activity in previous studies [43-45]. Phytochemicalanalysis identified polyphenols, alkaloids and other bio-
active compounds in the extract, which can also contribute
towards the observed central stimulating and analgesic
activities.
Conclusions
Present study revealed the central stimulating and anal-
gesic activities of ETAS, which strongly supports its use in
traditional medicine. Our current research findings dem-
onstrated scientific rationale for the traditional uses of this
plant as a central stimulant and analgesic. Interestingly,
the extract showed both peripheral and central analgesic
activity in established in vivo models. In addition, HPLC
and phytochemical analysis identified different bioactive
phytoconstituents including polyphenols and alkaloids
which might be responsible for observed pharmacological
activities. However, further study need to carry out to iso-
late pure bioactive compounds responsible for these activ-
ities with its mechanism of action.
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